HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study

Jason W.D. Hearn(University of Michigan–Ann Arbor), Ghada AbuAli(Cleveland Clinic Lerner College of Medicine), Chad A. Reichard(Kidney Associates), C.A. Reddy, Cristina Magi‐Galluzzi, Kai‐Hsiung Chang(Cleveland Clinic Lerner College of Medicine), Rachel E. Carlson(Mayo Clinic in Florida), Laureano J. Rangel(Mayo Clinic in Florida), Kevin Reagan(Mayo Clinic in Arizona), Brian J. Davis(Mayo Clinic in Arizona), R. Jeffrey Karnes(Mayo Clinic in Arizona), Manish Kohli(Mayo Clinic in Arizona), Donald J. Tindall(Mayo Clinic in Arizona), Eric A. Klein(Kidney Associates), Nima Sharifi(Kidney Associates)
The Lancet Oncology
September 2, 2016
Cited by 135Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis